Pasar al contenido principal

MODELO MULTIESCALA DE PATOLOGIAS CARDIACAS Y OPTIMIZACION DE TERAPIAS PERSONALIZADAS

PID2019-104356RB-C41

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POLITÈCNICA DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Contribución de congreso (ConferenceOutput)

Reduced Myofilament Contraction in Human Heart Failure. Insights From Electromechanical Simulations

  • Mora-Fenoll, María Teresa|||0000-0002-8069-2486
  • Trenor Gomis, Beatriz Ana|||0000-0001-9166-6112
  • Gutiérrez, Sofía
  • Dasi, Albert
  • Gómez García, Juan Francisco
[EN] Intracellular Ca2+ is the main activator of myofilament contraction and the altered Ca2+ handling observed in failing cells has been established as the leading cause of reduced inotropy in heart failure. Electrophysiological studies usually quantify Ca2+ transients to estimate contractile effects. However, heart failure remodeling of myofilaments also occurs, modifying the correlation between Ca2+ and force. The aim of this study was to analyze myofilament tension generated by action potentials in human heart failure. In a ventricular electromechanical model we investigated cellular contraction force associated with intracellular Ca2+ in heart failure by implementing the characteristic electrophysiological, beta-adrenergic, and mechanical changes. Despite the inotropic myofilament remodeling induced by heartfailure, the maximal active tension in failing cells was one third of the force generated in normal cells. With isoproterenol, beta-adrenergic stimulation increased systolic Ca2+, which enhanced myofilament tension by up to 150%, but failing cells also showed a smaller contraction force compared to normal. We observed that contractility was very sensitive to changes in intracellular Ca2+, confirming that increasing Ca2+ peak would improve contraction in heart failure., This work was partially supported by the "Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020" from the Ministerio de Ciencia e Innovación y Universidades (PID2019-104356RB-C41/AEI/10.13039/501100011033) and by the Dirección general de PolíticaCientífica de la Generalitat Valenciana (PROMETEO/2020/043). MTM is being funded by "Programa de Ayudas de Investigación y Desarrollo (PAID-01-17)" from the Universitat Politècnica de València